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Abstract
Purpose/Objectives—To explore the impact of health professionals’ recommendations for 
medical follow-up among colorectal cancer (CRC) survivors.
Design—Cross-sectional survey.
Setting—Mailed surveys and telephone interviews with CRC survivors in California.
Sample—593 adults diagnosed with a primary CRC six to seven years before the time of the 
study.
Methods—Participants were identified through California Cancer Registry records and invited to 
take part in a survey delivered via mail or through telephone interview.
Main Research Variables—The survey assessed cancer history, current preventive health 
practices, health status, demographics, and other cancer-related experiences.
Findings—More than 70% of CRC survivors received recommendations for routine checkups, 
surveillance colonoscopy, or other cancer screenings after completing CRC treatment, and 18%–
22% received no such recommendations. Recommendations were sometimes given in writing. 
Receiving a recommendation for a specific type of follow-up was associated with greater 
adherence to corresponding guidelines for routine checkups, colonoscopy, mammography, and 
Papanicolaou testing. Receiving written (versus unwritten) recommendations led to greater 
adherence only for colonoscopy.
Conclusions—Most CRC survivors reported receiving recommendations for long-term medical 
follow-up and largely adhered to guidelines for follow-up. Receiving a health professional’s 
recommendation for follow-up was consistently associated with patient adherence, and limited 
evidence showed that recommendations in written form led to greater adherence than unwritten 
recommendations.
Implications for Nursing—Given the increasingly important role of the oncology nurse in 
survivorship care, nurses can be instrumental in ensuring appropriate surveillance and follow-up 
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care among CRC survivors. Conveying recommendations in written form, as is done in 
survivorship care plans, may be particularly effective.
Keywords
cancer survivorship; adherence; cancer surveillance; colorectal cancer; long-term care; public 
health
People diagnosed with colorectal cancer (CRC) are now living longer after diagnosis than 
they did 30 years ago (Howlader et al., 2013), but heightened risks for cancer recurrence, 
second primary cancers, and other health problems are a concern during this lengthened 
phase of survivorship. To manage these risks and facilitate early detection of subsequent 
disease, cancer survivors are advised to follow a schedule of routine medical checkups, 
screenings, and surveillance (Desch et al., 2005; National Comprehensive Cancer Network 
[NCCN], 2012).
Compared with non-cancer controls, cancer survivors generally report higher rates of 
recommended cancer screenings (Bellizzi, Rowland, Jeffery, & McNeel, 2005; Fairley, 
Hawk, & Pierre, 2006; Hudson et al., 2009; Trask et al., 2005). However, a systematic 
review on post-treatment surveillance of CRC survivors concluded that 20%–49% of 
survivors are nonadherent with recommendations for surveillance colonoscopy at five years 
postdiagnosis, and as many as 23% of survivors attend fewer than the number of 
recommended office visits (Carpentier, Vernon, Bartholomew, Murphy, & Bluethmann, 
2013). Given the potential health benefits (e.g., increased survival) associated with 
undergoing recommended surveillance after CRC treatments (Figueredo et al., 2003; Jeffery, 
Hickey, & Hider, 2007; Renehan, Egger, Saunders, & O’Dwyer, 2002; Tjandra & Chan, 
2007), underuse of appropriate follow-up is an issue of growing public health concern.
Research has revealed that CRC survivors who are African American, under- or uninsured, 
and who have more comorbidities are among the least likely to undergo post-treatment 
surveillance (Carpentier et al., 2013; Hudson et al., 2009; Rolnick et al., 2005; Rulyak, 
Mandelson, Brentnall, Rutter, & Wagner, 2004). Other characteristics have been 
inconsistently reported across studies, and a need remains to identify modifiable factors 
associated with follow-up care for CRC survivors.
A potential driver of appropriate follow-up care after cancer involves recommendations for 
follow-up in the form of survivorship care plans (SCPs). In From Cancer Patient to Cancer 
Survivor: Lost in Transition, the Institute of Medicine (Hewitt, Greenfield, & Stovall, 2006) 
recommended that every patient with cancer who is completing primary treatment be 
provided with a comprehensive treatment summary and a written follow-up plan, referred to 
as an SCP, that details evidence-based standards of care for protecting health after cancer. 
According to the IOM, SCPs should include written recommendations for medical follow-up 
and surveillance to be performed routinely after treatment ceases, detailing how often and 
where survivors should be seen for their visits and screening tests. Although the IOM report 
received widespread acclaim and launched a nationwide call for SCPs, progress has been 
slow, and many cancer survivors continue to report never receiving written documents or 
materials resembling SCPs (Jabson & Bowen, 2013; Sabatino et al., 2013). The slow rate of 
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SCP uptake has driven investigations on the barriers to developing and delivering SCPs, 
which have uncovered a number of logistical challenges in implementing the IOM 
recommendations (Dulko et al., 2013). There is a lack of evidence demonstrating the 
efficacy of SCPs to affect care received or survivor outcomes post-treatment. Only a few 
studies have directly examined this issue, one of which used National Health Interview 
Survey (NHIS) data and found that receiving written instructions for follow-up was 
associated with receiving provider recommendations for surveillance among breast and 
cervical cancer survivors, but not with actual follow-up completion (Sabatino et al., 2013). 
However, Commission on Cancer ([COC], 2012) standards required that all COC-accredited 
cancer programs began delivering SCPs to increasing proportions of eligible patients 
beginning in 2015.
While research among general, non-cancer populations has demonstrated that a health 
professional’s recommendation for screening is a powerful influence on actual screening 
behavior (Brawarsky, Brooks, Mucci, & Wood, 2004; Guessous et al., 2010; Subramanian, 
Klosterman, Amonkar, & Hunt, 2004), scant evidence exists of this phenomenon among 
cancer survivors. An assumption underlying the push for SCP use is that recommendations 
for medical follow-up in the form of SCPs will lead to greater adherence with guidelines for 
follow-up; however, little evidence has been reported to support this presumption. 
Therefore, the goal of the current study was to examine the association between health 
professionals’ recommendations for follow-up and actual follow-up received by CRC 
survivors in a population-based sample.
The Prevention Among Colorectal Cancer Survivors (PACCS) study by the Centers for 
Disease Control and Prevention (CDC) was initiated to assess the health status, health 
behaviors, and medical follow-up of CRC survivors more than five years after diagnosis and 
to identify barriers to practicing healthy behaviors and receiving recommended follow-up 
after treatment for CRC. This population-based sample was used in the current study to 
examine survivors’ self-reported follow-up care as a function of recommendations made to 
them by health professionals. The authors also examined the method in which 
recommendations were given, whether they were in written form or not. The authors 
expected that any recommendations received by survivors would improve adherence to 
follow-up care and that this relationship would be stronger if recommendations were given 
in writing.
Methods
Participants for the PACCS study were recruited through the California Cancer Registry 
(CCR), operated in early 2010 by the Public Health Institute (PHI). ICF International, a 
company that provides research and evaluation services for government and businesses, 
served as CDC’s contractor for the study. All recruitment and study methods were approved 
by the institutional review boards of four organizations (CDC, ICF International, PHI, and 
CCR). CCR ascertained from their records a sampling frame of 11,168 cases of CRC 
diagnosed in California from 2003–2004. These sampling years were chosen to identify 
cancer survivors diagnosed more than five years prior to the time of planned data collection. 
Within this sampling frame, they applied the initial study eligibility criteria, which included 
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(a) having a primary cancer in a localized or regional stage, (b) having no previous cancer 
diagnosis, (c) being a resident of California at the time of diagnosis, (d) being aged 18 years 
or older at the time of diagnosis, (e) having a current vital status, (f) not having been 
contacted in the past 12 months to participate in any other studies using the CCR database, 
and (g) having no “do not contact” flag on record. Of the 11,168 cases, 10,315 met the initial 
eligibility criteria and were used as the sampling pool. The authors stratified eligible cases 
by race and ethnicity groups and oversampled minority racial and ethnic groups to obtain 
more accurate population estimates. A total of 1,920 cases were then randomly selected for 
recruitment, and additional eligibility criteria were applied. Survivors were ineligible if they 
were unable to complete the survey in English or because of mental or extreme physical 
incompetence (see Figure 1). PHI sent 1,781 advance letters to potentially eligible survivors 
who had not been excluded before or during the process of physician notification.
Recruitment efforts followed the Tailored Design Method (Dillman, 2007), which consisted 
of mailing, sequentially, an initial survey packet, a reminder postcard at two weeks, and a 
follow-up survey packet at four weeks. Nonresponders were contacted by telephone and 
invited to complete the survey via telephone interview. The survey packet included a cover 
letter, informed consent document, study questionnaire, $10 incentive, pen, and a pre-
addressed, postage-paid envelope for returning the questionnaire. All recruitment and data 
collection took place in early 2010.
Questionnaire Content
The PACCS survey contained previously validated measures and scales, as well as novel 
questions developed for the study. The present analysis used the following variables: past 
and current health, medical follow-up, recommendations, and demographics.
Questions were asked to determine the method of diagnosis and any current cancer 
treatments. Survivors undergoing active treatment for any cancer were excluded from the 
analysis. General health status was measured using a five-point Likert-type scale.
Survivors were also asked how long it had been since their last colonoscopy, routine 
checkup, mammogram (females only), and cervical screening by Papanicolaou (Pap) test 
(females only). Questions and closed-ended responses were modified from the cancer 
control module of the NHIS.
Participants were asked if, since completing treatment, they had received guidance from a 
doctor, nurse, or other health professional about getting medical follow-up, including routine 
checkups, colonoscopy, mammogram, and Pap testing. Participants who answered “yes” 
were asked whether the guidance had been written or printed for them. The authors 
categorized follow-up instructions as written, unwritten, and none. Similar questions were 
included on the cancer control module of the NHIS and have been categorized similarly 
(Sabatino et al., 2013). Standard questions were asked about age, gender, race, ethnicity, 
marital status, educational attainment, employment status, and health insurance.
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Defining Adherence With Recommendations
Literature reviews were conducted in 2008 and during data collection in 2010 to determine 
current recommendations for surveillance colonoscopy, routine checkups, and cancer 
screening by mammography and Pap testing. Recommendations specific to CRC survivors 
were available for colonoscopy and routine checkups, and recommendations for cervical and 
breast cancer screening were adopted from those developed for the general public. 
Adherence with follow-up for CRC survivors five to seven years postdiagnosis was based on 
guidelines from the NCCN and the American Cancer Society (2005) (Rex et al., 2006), the 
American Society of Clinical Oncology (Desch et al., 2005), the American 
Gastroenterological Association (Winawer et al., 2003), and the U.S. Preventive Services 
Task Force (2013). Survivors were considered adherent with surveillance colonoscopy if 
they had undergone colonoscopy within the past three years, with routine checkups if they 
had been seen within the past six months, with mammography (among women aged 40 years 
or older) if they had had one within the past two years, and with cervical screening (for 
women younger than age 65 years with no previous hysterectomy) if they had received a 
Pap test within the past three years.
Statistical Analysis
The authors calculated base weights for the race and ethnicity totals that were equal to the 
inverse selection probability. The final weights were then obtained by poststratification, 
which better reflected the racial and age distribution in the survivor population. Descriptive 
statistics were used to examine demographic characteristics, receipt of recommendations for 
checkups and screening, and adherence to recommendations. Associations were assessed 
between survivor characteristics and adherence to recommendations for each screening test 
and checkup with the Rao-Scott chi-square test (Rao & Scott, 1987). Differences between 
written and unwritten recommendations were examined with linear contrasts separately for 
checkups and each screening type. To improve the reliability of the estimates, the authors 
dichotomized the health status variable to excellent, very good, or good versus fair or poor 
and insurance status to none, public assistance only, Medicare, or Medicaid versus private or 
military.
Multivariable logistic regression models were used to calculate adjusted percentage 
estimates (predicted margins) (Graubard & Korn, 1999) and their differences and ratios, and 
to examine the association between receiving a recommendation and undergoing routine 
checkups, colonoscopy, and mammography after controlling for other survivor 
characteristics. Cervical screening estimates were not included in this analysis because of 
insufficient numbers. The survivor characteristics that the authors controlled included 
gender (when applicable), education, insurance status, marital status, and health status. Only 
variables significantly associated (p < 0.05) with their respective outcome were left in the 
model. For this analysis, the authors further dichotomized the following variables: education 
(less than some college versus some college or more) and marital status (married or living 
together versus divorced, widowed, separated, or never married).
To generalize the results to the population of CRC survivors within the state of California, 
data were analyzed with SAS® and SUDAAN, version 10, which computed weighted 
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population estimates and 95% confidence intervals (CIs) and accounted for the complex 
survey design and nonresponse.
Results
Response rates were based on 1,781 cases contacted for the study via a mailed letter sent in 
advance of the survey packet. Following the advance letter, the sampling pool decreased by 
those who refused participation (n = 84), were deemed ineligible (n = 105), and were found 
to have invalid addresses with no additional contact information (n = 179). Survey packets 
were then mailed to 1,414 survivors, which yielded 593 completed surveys (582 returned by 
mail; 11 conducted via telephone interview). The unadjusted response rate (44%) was 
calculated as the number of completed surveys divided by the number of potentially eligible 
cases in the physician-consented sample, which included all refusals, incomplete responses, 
and nonresponders. Because this rate assumes every instance of nonresponse represents an 
eligible participant, the authors also calculated an adjusted response rate (46%), which 
estimates the same proportion of eligibility (85%) in nonresponse cases as in the cases with 
which contact was made. A cooperation rate of 64% was calculated as the proportion of 
eligible participants with whom contact was made who agreed to participate. One participant 
with missing race and ethnicity information was excluded from the analysis because weights 
could not be calculated.
Survivors were, on average, 6.2 years past their primary diagnosis of CRC (range = 5.2–7.2 
years). Equal proportions of males and females participated, the mean age was 73.8 years, 
and 65% were Non-Hispanic Caucasian (see Table 1). More than 60% had some college 
education or had completed college. The vast majority were married or living with a partner 
and reported their health as good, very good, or excellent. About 60% were insured through 
Medicare, Medicaid, or public assistance only.
A majority of participants (71%–76%) received written or unwritten recommendations for 
routine checkups, surveillance colonoscopy, and other cancer screenings; however, 18%–
22% received no such guidance (see Figure 2). Although 44% and 58% received 
recommendations in writing for Pap testing and mammography, respectively, 28% and 13% 
received only unwritten recommendations for Pap testing and mammography, respectively.
Adherence to guidelines for routine checkups was 90% (95% CI [87.5, 93]), and adherence 
with surveillance colonoscopy was 69% (95% CI [65, 73.7]). Among those eligible, 86% 
(95% CI [77.4, 94]) were adherent with recommendations for Pap testing, and 71% (95% CI 
[64.8, 77]) were adherent with recommendations for mammography.
Survivors with Medicare, Medicaid, public assistance only, or no insurance were less likely 
to be adherent to the schedule of recommended routine checkups (88%) than were those 
with private or military insurance (94%) (p = 0.046). A significant association was observed 
between general health and adherence to colonoscopy guidelines (p = 0.035), where 
survivors with fair or poor health had lower adherence with colonoscopy (59%) than those 
with good to excellent health (72%). Adherence to recommendations for mammography 
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among survivors with poor health was lower (49%, 95% CI [35.4, 62.8]) than adherence 
among those with good to excellent health (78%, 95% CI [72, 84.7]) (see Table 2).
Adherence was associated with a health professional’s recommendation for each type of 
follow-up. For routine checkups and each of the screening tests, those not having received a 
recommendation were less likely to be up to date with them than those having received a 
written or unwritten recommendation (p < 0.05 for checkups, p < 0.001 for each screening 
test). However, receiving a written recommendation rather than an unwritten one was only 
significantly associated with higher adherence for colonoscopy (p < 0.05). Although 
adherence with cervical screening recommendations for eligible women younger than age 65 
years increased from 48% to more than 96% given a recommendation for that test (p < 
0.001), these results should be interpreted with caution because of the small number of 
women who did not receive recommendations.
Further analysis using multivariable models revealed that, after controlling for demographic 
variables, differences in the adjusted percentages of adherence varied by type of 
recommendation (any recommendation versus no recommendation) from 10% (p = 0.016) 
for checkups to 41% (p < 0.001) for colonoscopy and 59% (p < 0.001) for mammography. 
Associations between recommendations and adherence to these recommendations varied in 
a similar manner with decreasing prevalence ratios. Survivors with any recommendation 
were more likely to adhere to the recommendation than those with no recommendation for 
routine checkup (adjusted prevalence ratio [aPR] = 0.89, p = 0.004), colonoscopy (aPR = 
0.48, p < 0.001), and mammography (aPR = 0.3, p < 0.001).
Discussion
Efforts to improve survivors’ long-term health have increasingly focused on the importance 
of medical follow-up and early detection of subsequent disease. The field of oncology 
nursing is undergoing similar shifts in focus, with expanded emphases on the stage of care 
beyond active treatment, including activities related to increasing adherence with 
recommended cancer prevention, detection, and surveillance. In this group of CRC survivors 
six to seven years after diagnosis, adherence with recommended routine checkups was high 
(90%), but adherence with surveillance colonoscopy was substantially lower (69%), which 
is consistent with a review by Carpentier et al. (2013) on the surveillance patterns of CRC 
survivors. However, the current study went a step further in analyzing these follow-up 
patterns in light of health professionals’ recommendations, an area in which oncology nurses 
can play a critical role.
By recruiting survivors through a cancer registry, the authors were able to present 
population-based estimates from a diverse group of CRC survivors. The findings of the 
current study go beyond previous research that has identified sociodemographic 
characteristics associated with CRC survivors’ medical follow-up (Carpentier et al., 2013; 
Rolnick et al., 2005; Rulyak et al., 2004) because the current study reveals a modifiable 
influence on follow-up care. The findings suggest that health professionals’ 
recommendations for medical follow-up are significantly related to actual follow-up 
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behavior and, therefore, are of paramount importance to the early detection of recurrence, 
polyps, and precancerous lesions.
About one-fifth of survivors received no recommendations for medical follow-up after CRC 
treatment had ended, but the majority received recommendations, and more than half of 
those received them in written form. Whereas receiving an unwritten or written 
recommendation were both associated with greater adherence to guidelines for routine 
checkups, colonoscopy, mammography, and Pap testing, receiving a written 
recommendation rather than an unwritten one appeared to offer an additional boost to 
adherence with colonoscopy. Of the variables examined as possible covariates of follow-up, 
a health professional’s recommendation demonstrated the strongest association with 
adherence.
Examining factors associated with follow-up after CRC treatment is an important step in 
identifying ways to improve the long-term health of survivors. SCPs have been advocated as 
a means by which survivors can become informed of recommendations for long-term 
follow-up and are intended to serve the role of a direct and tangible recommendation from 
the healthcare team. Although the full impact of SCPs will not be known until many years 
after they become common practice, results from the current study indicate that 
recommendations included in SCPs are likely to increase medical follow-up and 
surveillance. Further research is needed to examine the impact of SCPs using prospective 
designs that compare different modes of delivery and evaluate the costs, barriers, and 
benefits of full-scale implementation. With the new COC standards, which require 
multifaceted change in survivorship care, comes a wealth of new research opportunities for 
evaluating the process and outcomes of these new components of care. Best practices will 
need to be tested and identified regarding the process of communicating information about 
follow-up to survivors and others closely involved; coordinating medical follow-up between 
survivors and healthcare professionals; and referring survivors to survivorship resources in 
the cancer center, community, and online (Grant, Economou, & Ferrell, 2010). With each 
change that is made to standard survivorship care, assessing the equity of support services to 
survivors from different backgrounds and the effectiveness of services offered will be 
important.
Limitations
Although a population-based sampling frame was used, the adjusted response rate was 46%, 
and the potential for response bias cannot be ruled out. However, the cooperation rate (i.e., 
proportion of those with whom the authors made contact who agreed to participate) was 
higher (64%). Although recruiting survivors from a cancer registry allowed for a diverse 
sample, the cross-sectional sampling and self-report methods prevented the verification of 
medical follow-up. Error was also possible in the degree to which participants recalled 
receiving recommendations in under- and overreporting. However, previous research that 
has compared CRC screening history via self-report versus medical record has found that 
self-report is largely reliable, particularly with regard to colonoscopy (Jones, Mongin, 
Lazovich, Church, & Yeazel, 2008; Khoja, McGregor, & Hilsden, 2007; Partin et al., 2008).
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In addition to traditional roles in coordinating and providing cancer care, oncology nurses 
can play an important role in facilitating the transition of patient with cancer to survivor and 
will likely have increasingly critical responsibilities related to communicating 
recommendations for follow-up care. The responsibilities for creating and delivering SCPs 
will, in many instances, reside with oncology nurses, nurse navigators, and other care 
providers meeting the COC requirements surrounding SCP delivery, further elevating the 
oncology nurse’s role in survivorship care. Future research is needed to examine the impact 
of activities and answer questions related to the nurse’s expanding role in developing and 
delivering SCPs.
Conclusions
Six to seven years after a CRC diagnosis, the authors found that 18%–22% of survivors had 
not received any recommendations for follow-up care and surveillance. Those who did 
receive a recommendation for follow-up were more likely to undergo that follow-up, and 
receiving a recommendation for colonoscopy in writing appeared more influential than 
receiving it in an unwritten form. Successful communication regarding medical follow-up 
after treatment is essential to optimizing health after cancer, and the oncology nurse can play 
a pivotal role in the communication of this information. As the field of long-term 
survivorship care progresses, nurses must continue to monitor the health behaviors of 
survivors and look for opportunities to encourage appropriate follow-up and prevention 
practices.
Acknowledgments
The authors gratefully acknowledge the project managers and staff from the Public Health Institute and the 
California Cancer Registry for participating in sampling and recruitment for the study; Naomi Freedner, MPH, and 
Ashley Mark at ICF International, for overseeing the collection and assembly of data; and Steve Leadbetter, MS, 
for providing consultation on methodology.
References
Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: Examining 
opportunities for cancer control intervention. Journal of Clinical Oncology. 2005; 23:8884–
8893.10.1200/JCO.2005.02.2343 [PubMed: 16314649] 
Brawarsky P, Brooks DR, Mucci LA, Wood PA. Effect of physician recommendation and patient 
adherence on rates of colorectal cancer testing. Cancer Detection and Prevention. 2004; 28:260–
268.10.1016/j.cdp.2004.04.006 [PubMed: 15350629] 
Carpentier MY, Vernon SW, Bartholomew LK, Murphy CC, Bluethmann SM. Receipt of 
recommended surveillance among colorectal cancer survivors: A systematic review. Journal of 
Cancer Survivorship. 2013; 7:464–483.10.1007/s11764-013-0290-x [PubMed: 23677524] 
Commision on Cancer. Cancer program standards 2012: Ensuring patientcentered care. 2012. 
Retrieved from https://www.facs.org/~/media/files/quality%20programs/cancer/coc/
programstandards2012.ashx
Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Petrelli NJ. Colorectal 
cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. 
Journal of Clinical Oncology. 2005; 23:8512–8519.10.1200/JCO.2005.04.0063 [PubMed: 
16260687] 
Hawkins et al. Page 9













Dillman, D. Mail and Internet surveys: The tailored design method. 2. Hoboken, NJ: John Wiley and 
Sons; 2007. 
Dulko D, Pace CM, Dittus KL, Sprague BL, Pollack LA, Hawkins NA, Geller BM. Barriers and 
facilitators to implementing cancer survivorship care plans. Oncology Nursing Forum. 2013; 
40:575–580.10.1188/13.ONF.575-580 [PubMed: 24161636] 
Fairley TL, Hawk H, Pierre S. Health behaviors and quality of life of cancer survivors in 
Massachusetts, 2006: Data use for comprehensive cancer control. Preventing Chronic Disease. 
2006; 7:1–8.
Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, Zwaal C. Follow-up of 
patients with curatively resected colorectal cancer: A practice guideline. BMC Cancer. 2003; 
3:26.10.1186/1471-2407-3-26 [PubMed: 14529575] 
Grant M, Economou D, Ferrell BR. Oncology nurse participation in survivorship care. Clinical Journal 
of Oncology Nursing. 2010; 14:709–715.10.1188/10.CJON.709-715 [PubMed: 21112849] 
Graubard BI, Korn EL. Predictive margins with survey data. Biometrics. 1999; 55:652–659.10.1111/j.
0006-341X.1999.00652.x [PubMed: 11318229] 
Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN. Colorectal cancer screening 
barriers and facilitators in older persons. Preventive Medicine. 2010; 50:3–10.10.1016/j.ypmed.
2009.12.005 [PubMed: 20006644] 
Hewitt, M.; Greenfield, S.; Stovall, E. From cancer patient to cancer survivor: Lost in transition. 
Washington, DC: National Academies Press; 2006. 
Howlader, N.; Noone, A.; Krapcho, M.; Garshell, J.; Neyman, N.; Altekruse, SF.; Cronin, KA., 
editors. SEER cancer statistics review: 1975–2010. 2013. Retrieved from http://
seer.cancer.gov/csr/1975_2010/sections.html
Hudson SV, Hahn KA, Ohman-Strickland P, Cunningham RS, Miller SM, Crabtree BF. Breast, 
colorectal and prostate cancer screening for cancer survivors and non-cancer patients in 
community practices. Journal of General Internal Medicine. 2009; 24(Suppl 2):S487–
S490.10.1007/s11606-009-1036-3 [PubMed: 19838855] 
Jabson JM, Bowen DJ. Cancer treatment summaries and follow-up care instructions: Which cancer 
survivors receive them? Cancer Causes and Control. 2013; 24:861–871. [PubMed: 23385334] 
Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal 
cancer. Cochrane Database of Systematic Reviews. 2007; 
1:CD002200.10.1002/14651858CD002200.pub2 [PubMed: 17253476] 
Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW. Validity of four self-reported colorectal 
cancer screening modalities in a general population: Differences over time and by intervention 
assignment. Cancer Epidemiology, Biomarkers and Prevention. 2008; 17:777–
784.10.1158/1055-9965.EPI-07-0441
Khoja S, McGregor SE, Hilsden RJ. Validation of self-reported history of colorectal cancer screening. 
Canadian Family Physician. 2007; 53:1192–1197. [PubMed: 17872816] 
National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Colon cancer. 
2012. [v.3.2012]. Retrieved from http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf
National Comprehensive Cancer Network & American Cancer Society. Colon and rectal cancer: 
Treatment guidelines for patients. 2005. Retrieved from http://www.colorectal-cancer.ca/IMG/pdf/
NCCN-colorectal-guidelines.pdf
Partin MR, Grill J, Noorbaloochi S, Powell AA, Burgess DJ, Vernon SW, Fisher DA. Validation of 
self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer 
Epidemiology, Biomarkers and Prevention. 2008; 17:768–776.10.1158/1055-9965.EPI-07-0759
Rao J, Scott A. On simple adjustments to chi-square tests with sample survey data. Annals of 
Statistics. 1987; 15:385–397.10.1214/aos/1176350273
Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after 
curative resection for colorectal cancer: Systematic review and meta-analysis of randomised trials. 
BMJ. 2002; 324:813.10.1136/bmj.324.7341.813 [PubMed: 11934773] 
Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, Winawer SJ. Guidelines for colonoscopy 
surveillance after cancer resection: A consensus update by the American Cancer Society and US 
Hawkins et al. Page 10













Multi-Society Task Force on Colorectal Cancer. CA: A Cancer Journal for Clinicians. 2006; 
56:160–167.10.1053/j.gastro.2006.03.013 [PubMed: 16737948] 
Rolnick S, Hensley Alford S, Kucera GP, Fortman K, Ulcickas Yood M, Jankowski M, Johnson CC. 
Racial and age differences in colon examination surveillance following a diagnosis of colorectal 
cancer. Journal of the National Cancer Institute Monographs. 2005; 35:96–101.10.1093/
jncimonographs/lgi045 [PubMed: 16287893] 
Rulyak SJ, Mandelson MT, Brentnall TA, Rutter CM, Wagner EH. Clinical and sociodemographic 
factors associated with colon surveillance among patients with a history of colorectal cancer. 
Gastrointestinal Endoscopy. 2004; 59:239–247.10.1016/S0016-5107(03)02531-8 [PubMed: 
14745398] 
Sabatino SA, Thompson TD, Smith JL, Rowland JH, Forsythe LP, Pollack L, Hawkins NA. Receipt of 
cancer treatment summaries and follow-up instructions among adult cancer survivors: Results 
from a national survey. Journal of Cancer Survivorship. 2013; 7:32–43.10.1007/s11764-012-0242-
x [PubMed: 23179495] 
Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening 
guidelines: A review. Preventive Medicine. 2004; 38:536–550.10.1016/j.ypmed.2003.12.011 
[PubMed: 15066356] 
Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: A meta-analysis. 
Diseases of the Colon and Rectum. 2007; 50:1783–1799.10.1007/s10350-007-9030-5 [PubMed: 
17874269] 
Trask PC, Rabin C, Rogers ML, Whiteley J, Nash J, Frierson G, Pinto B. Cancer screening practices 
among cancer survivors. American Journal of Preventive Medicine. 2005; 28:351–356.10.1016/
j.amepre.2005.01.005 [PubMed: 15831340] 
U.S. Preventive Services Task Force. Published recommendations. 2013. Retrieved from http://
www.uspreventiveservicestaskforce.org/BrowseRec/Index
Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Simmang C. Colorectal cancer screening 
and surveillance: Clinical guidelines and rationale—Update based on new evidence. 
Gastroenterology. 2003; 124:544–560.10.1053/gast.2003.50044 [PubMed: 12557158] 
Hawkins et al. Page 11














About 18%–22% of survivors did not receive recommendations for medical follow-up 
and surveillance after their treatment was complete.
Survivors who received a recommendation for follow-up were more likely to undergo 
that follow-up.
Receiving a recommendation for surveillance colonoscopy in writing appeared more 
effective than receiving it in an unwritten form.
Hawkins et al. Page 12













Figure 1. Sample Selection, Recruitment, and Response Rates
aExcluded cases following advance letters do not add to 1,414 because of overlap in reasons 
for exclusion.
bOne survey did not respond to the race and ethnicity question and was not used in analysis 
for a total sample size of 592.
CCR—California Cancer Registry; NCOA—National Change of Address database
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Figure 2. Estimated Percentages of Receipt of Any Recommendations for Follow-Up and 
Screening (N = 592)
Note. Women younger than age 40 years were excluded for mammogram (n = 2), and 
women older than age 65 with a previous hysterectomy were excluded for Papanicolaou 
testing (n = 214).
Note. Unknown and missing data were excluded.
Note. Percentages are weighted to the population of survivors.
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Table 1
Sample Characteristics (N = 592)
Characteristic n %a 95% CI
Gender
 Female 296 50 [44, 54.1]
 Male 295 50 [45.7, 54.9]
 Missing data 1 < 1 –
Age (years)
 Younger than 50 28 3 [1.9, 4]
 50–59 85 9 [6.9, 10.8]
 60–69 164 17 [14.1, 19.3]
 70–79 187 40 [35.5, 44.7]
 80–89 104 26 [21.2, 29.8]
 90 or older 24 6 [3.5, 8.3]
Race and ethnicity
 Non-Hispanic Caucasian 291 65 [63.2, 66.3]
 Hispanic 107 16 [14.9, 16.8]
 Non-Hispanic African American 101 6 [5.2, 5.8]
 Non-Hispanic Asian or Pacific Islander 84 13 [11.6, 13.8]
 Other or unknown 9 1 [0.8, 1.4]
Education
 Less than high school 85 14 [11, 17]
 High school graduate 111 20 [15.9, 23.2]
 Some college 191 31 [26.7, 35.1]
 College graduate 180 31 [27.2, 35.6]
 Missing data 25 4 [2.3, 5.9]
Marital status
 Married or living together 362 61 [56.3, 65.3]
 Divorced, widowed, or separated 172 31 [26.2, 34.8]
 Never married 35 5 [3.2, 7.2]
 Missing data 23 4 [1.9, 5.1]
Insurance status
 Medicare, Medicaid, or public assistance only 297 59 [54, 62.9]
 Private or military 260 36 [31.5, 40]
 Other 10 2 [0.6, 3.4]
 None 6 1 [0.14, 1.2]
 Missing data 19 3 [1.5, 4.7]
Method of diagnosis
 After symptoms or problems 304 48 [43.9, 53]
 Routine screening 242 44 [39, 48.2]
 Other 22 5 [2.5, 6.4]
 Missing data 24 4 [1.9, 5.1]
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Characteristic n %a 95% CI
General health
 Excellent or very good 214 36 [31.7, 40.5]
 Good 233 40 [35.5, 44.5]
 Fair or poor 124 22 [17.9, 25.5]
 Do not know, refused, or missing data 21 2 [1.2, 3.3]
a
Percentages are weighted to the population of survivors.
CI—confidence interval
Note. Because of rounding, percentages may not total 100.


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































Oncol Nurs Forum. Author manuscript; available in PMC 2016 May 01.
